🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Alan P. Kozikowski

Hadassah Medical Center

ORCID: 0000-0003-4795-5368

Also affiliated with Chembio (United States), MBio Diagnostics (United States), Molecular Theranostics (United States)

NeuroscienceBiochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 8 papers. Top paper: “Chemistry and biology of mercaptoacetamides as novel histone deacetylase inhibitors”.

Chemistry and biology of mercaptoacetamides as novel histone deacetylase inhibitors

Bioorganic & Medicinal Chemistry Letters(2005)10.1016/j.bmcl.2005.01.006
N/A
0.621DataRank · unranked
62 citations

Pavel A. Petukhov, Mira Jung, Alfredo Velena, Elena Eliseeva, Anatoly Dritschilo +2 more

Rational Design of Suprastat: A Novel Selective Histone Deacetylase 6 Inhibitor with the Ability to Potentiate Immunotherapy in Melanoma Models

Journal of Medicinal Chemistry(2020)10.1021/acs.jmedchem.0c00567
N/A
0DataRank · unranked
55 citations

Sida Shen, J. Ptáček, Maurício T. Tavares, Guiping Zhang, Jan Stránský +8 more

Mercaptoacetamide: A promising zinc-binding group for the discovery of selective histone deacetylase 6 inhibitors

European Journal of Medicinal Chemistry(2020)10.1016/j.ejmech.2020.112887
N/A
0DataRank · unranked
43 citations

Alan P. Kozikowski, Sida Shen, Maurício T. Tavares

Optimization of 2-Phenylcyclopropylmethylamines as Selective Serotonin 2C Receptor Agonists and Their Evaluation as Potential Antipsychotic Agents

Figshare(2020)10.17615/ms9t-0a86
N/A
0DataRank · unranked
0 citations

William C. Wetsel, Wei Lv, Bryan L. Roth, Oluseye K. Onajole, Arsen Gaisin +8 more

HDAC6 inhibition promotes α-tubulin acetylation and ameliorates CMT2A peripheral neuropathy in mice

Experimental Neurology(2020)10.1016/j.expneurol.2020.113281
N/A
0DataRank · unranked
62 citations

V. Wong, Christopher J. Costa, Marion C. McKinnon, David C. Goldberg, Michelle Swift +7 more

Design and synthesis of (2-(5-chloro-2,2-dimethyl-2,3-dihydrobenzofuran-7-yl)cyclopropyl)methanamine as a selective serotonin 2C agonist This Letter is dedicated to the lasting memory of Harry H. Wasserman, a connoisseur of heterocycles

UNC Libraries(2020)10.17615/mvqt-gd37
N/A
0DataRank · unranked
0 citations

Patrick M. Giguère, Bryan L. Roth, Wei Lv, Jianjun Cheng, Alan P. Kozikowski

Selectivity of Hydroxamate- and Difluoromethyloxadiazole-Based Inhibitors of Histone Deacetylase 6 In Vitro and in Cells

International Journal of Molecular Sciences(2023)10.3390/ijms24054720
N/A
0DataRank · unranked
29 citations

Ivan Šnajdr, Jiří Schimer, Zsófia Kutil, Jana Mikešová, Petra Baranová +6 more

Rational Drug Design Leading to the Identification of a Potent 5-HT 2C Agonist Lacking 5-HT 2B Activity

INDIGO (University of Illinois at Chicago)(2020)10.17615/5qmt-v586
N/A
0DataRank · unranked
0 citations

Andreas Svennebring, Alan P. Kozikowski, Niels Jensen, Bryan L. Roth, Sung Jin Cho +3 more